BLyS/APRIL dual inhibition for IgG4-RD: a prospective single-arm clinical trial of telitacicept

Ann Rheum Dis. 2023 Jun;82(6):881-883. doi: 10.1136/ard-2022-223529. Epub 2023 Jan 19.
No abstract available

Keywords: Autoimmune Diseases; B-Lymphocytes; Glucocorticoids.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't
  • Letter

MeSH terms

  • Autoimmune Diseases*
  • Glucocorticoids / pharmacology
  • Humans
  • Immunoglobulin G4-Related Disease*
  • Prospective Studies

Substances

  • TNFSF13 protein, human
  • telitacicept
  • Glucocorticoids